EURIPREDLIONEX DIAGNOSTICS AND THERAPEUTICS
EURIPRED (European Research Infrastructures for Poverty Related Diseases) is a collaborative infrastructure programme with the objective to reinforce the knowledge infrastructure across diseases. The ultimate aim is to speed the development of new tools (vaccines, drugs, microbicides) to combat Tuberculosis, HIV, Malaria, Hepatitis B and Hepatitis C. One of the key activities is providing reference reagents, services and trainings for free. EURIPRED is co-funded with € 8.5 million by the European Commission. Scientists from 17 research partners in 10 countries collaborate in this programme.
EURIPRED started in November 2013, is a 4-year project and has received funding from the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No 312661. Read the project in one page.
EURIPRED comprises a team of 17 globally leading organisations in the field of poverty related diseases. Read more>>
Free reference reagents and other services are available for poverty related diseases.
Read more >>
If you have any questions please contact us
Last Updated on